These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6131336)

  • 1. Modifications to indirect immunofluorescence tests on Lassa, Marburg, and Ebola material.
    van der Groen G; Kurata T; Mets C
    Lancet; 1983 Mar; 1(8325):654. PubMed ID: 6131336
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of betapropionolactone inactivated Ebola, Marburg and Lassa intracellular antigens in immunofluorescent antibody assay.
    Van der Groen G; Elliot LH
    Ann Soc Belg Med Trop; 1982 Mar; 62(1):49-54. PubMed ID: 7049096
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys.
    Johnson KM; Elliott LH; Heymann DL
    J Clin Microbiol; 1981 Nov; 14(5):527-9. PubMed ID: 7031084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to haemorrhagic fever viruses in Madagascar populations.
    Mathiot CC; Fontenille D; Georges AJ; Coulanges P
    Trans R Soc Trop Med Hyg; 1989; 83(3):407-9. PubMed ID: 2515626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral hemorrhagic fever antibodies in Nigerian populations.
    Tomori O; Fabiyi A; Sorungbe A; Smith A; McCormick JB
    Am J Trop Med Hyg; 1988 Mar; 38(2):407-10. PubMed ID: 3128130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of cross reactivity of rhabdovirus antibodies with Marburg and Ebola antigens in the indirect immunofluorescent antibody test.
    Van der Groen G; Elliot LH
    Ann Soc Belg Med Trop; 1982 Mar; 62(1):67-8. PubMed ID: 6179483
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stabilization of peroxidase conjugates used in enzyme immunoassay systems to detect Ebola and Marburg virus antigens].
    Pirozhkov AP; Borisevich IV; Snetkova OIu; Androshchuk IA; Syromiatnikova SI; Khmelev AL; Shatokhina IV; Kudrin VIu; Timofeev MA; Pantiukhov VB; Borisevich SV; Markov VI; Bondarev VP
    Vopr Virusol; 2010; 55(1):45-8. PubMed ID: 20364672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Method for the simultaneous detection of immunofluorescing antibodies to the causative agents of different hemorrhagic fevers].
    Lukashevich IS; van der Groen G
    Vopr Virusol; 1985; 30(5):624-6. PubMed ID: 3907144
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué.
    Ivanoff B; Duquesnoy P; Languillat G; Saluzzo JF; Georges A; Gonzalez JP; McCormick J
    Trans R Soc Trop Med Hyg; 1982; 76(6):719-20. PubMed ID: 7164137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marburg and Ebola virus antibodies in Kenyan primates.
    Johnson BK; Gitau LG; Gichogo A; Tukei PM; Else JG; Suleman MA; Kimani R
    Lancet; 1981 Jun; 1(8235):1420-1. PubMed ID: 6113374
    [No Abstract]   [Full Text] [Related]  

  • 11. Marburg, Ebola and Rift Valley Fever virus antibodies in East African primates.
    Johnson BK; Gitau LG; Gichogo A; Tukei PM; Else JG; Suleman MA; Kimani R; Sayer PD
    Trans R Soc Trop Med Hyg; 1982; 76(3):307-10. PubMed ID: 6810518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Marburg, Lassa and Ebola virus as cause of hemorrhagic fever].
    Siegert R
    Dtsch Med Wochenschr; 1978 Jul; 103(29):1176-81. PubMed ID: 352653
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemorrhagic (Marburg, Ebola, Lassa, and Bolivian) fevers: epidemiology, clinical pictures, and treatment].
    Borisevich IV; Markin VA; Firsova IV; Evseev AA; Khamitov RA; Maksimov VA
    Vopr Virusol; 2006; 51(5):8-16. PubMed ID: 17087059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivating Lassa and Marburg/Ebola viruses.
    Pereira MS
    Lancet; 1982 Jul; 2(8290):155. PubMed ID: 6123862
    [No Abstract]   [Full Text] [Related]  

  • 15. Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation.
    Elliott LH; McCormick JB; Johnson KM
    J Clin Microbiol; 1982 Oct; 16(4):704-8. PubMed ID: 7153317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an immunofluorescence focus assay for Ebola virus.
    Truant AL; Regnery RL; Kiley MP
    J Clin Microbiol; 1983 Aug; 18(2):416-9. PubMed ID: 6352735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against haemorrhagic fever viruses in Kenya populations.
    Johnson BK; Ocheng D; Gichogo A; Okiro M; Libondo D; Tukei PM; Ho M; Mugambi M; Timms GL; French M
    Trans R Soc Trop Med Hyg; 1983; 77(5):731-3. PubMed ID: 6419422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to Lassa and Lassa-like viruses in man and mammals in the Central African Republic.
    Georges AJ; Gonzalez JP; Abdul-Wahid S; Saluzzo JF; Meunier DM; McCormick JB
    Trans R Soc Trop Med Hyg; 1985; 79(1):78-9. PubMed ID: 2986324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corning HYPERFlask
    Kearney BJ; Voorhees MA; Williams PL; Olschner SP; Rossi CA; Schoepp RJ
    J Virol Methods; 2017 Apr; 242():9-13. PubMed ID: 28012899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever.
    Grolla A; Lucht A; Dick D; Strong JE; Feldmann H
    Bull Soc Pathol Exot; 2005 Sep; 98(3):205-9. PubMed ID: 16267962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.